The GLP-1 Effect: Defining A New Era of Wellness
• • • • • •
How could GLP-1 insights reshape your consumer marketing and approach? Discover the transformative potential with Suzy’s custom trackers today!
By: Amy Frankenthaler, Customer Success Manager
Remember the good ol' days of quarantine? You know, the days when sourdough starters were all the rage, Zoom happy hours were our main source of social interaction, and our waistlines were steadily expanding as we comforted ourselves with quarantine snacks. Fast forward to 2024, and we’re witnessing a seismic shift in how people approach weight loss, thanks in large part to a class of medications known as GLP-1s.
Curious about the basics? Learn how GLP-1s are Transforming Lives and Industries One Injection at a Time!
The Pandemic Effect: How COVID-19 Fueled the GLP-1 Boom
The pandemic brought with it a host of challenges, including weight gain. With gyms closed and stress levels at an all-time high, many people found themselves putting on weight. As the world started to emerge from lockdown, the demand for effective weight loss solutions skyrocketed.
Enter GLP-1 medications. These drugs quickly gained traction as a viable solution for those looking to shed pandemic pounds. By 2030, the market for GLP-1 drugs is expected to exceed $100 billion, with more and more people turning to these medications as their go-to weight loss solution. Projections show that funding for obesity-related medications is said to surpass that of cancer…yes CANCER. How we’ve approached weight loss pre-pandemic has changed leaps and bounds post-pandemic, thanks to a simple monthly injection. Is this the “magic pill” or “magic injection” we always dreamed of?
More pharmaceutical companies are shifting their focus to Anti-Obesity Medications (AOM), and this is just the beginning. We are also seeing a shift in what certain insurance companies will pay for certain diabetes versus obesity medications.AOMs are expected to significantly impact obesity-related costs. By reducing obesity rates, these medications can lead to improved overall health outcomes, which in turn can lower healthcare expenditures related to obesity-related complications, such as Type 2 diabetes, cardiovascular diseases, and certain cancers. Additionally, decreasing obesity prevalence could also reduce productivity losses and other economic burdens associated with obesity, potentially saving billions in healthcare costs globally by 2035. The benefits of GLP-1 will have a ripple effect across industries and this is just the beginning.
Why This Change Matters
So, why does all this matter? Because the rise of GLP-1s is more than just a trend; it's a revolution that’s forcing industries to adapt or be left behind. Weight loss companies that have long relied on diet plans and calorie counting are now scrambling to integrate these medications into their offerings. WeightWatchers, for instance, recently began offering GLP-1 prescriptions through its in-house clinic, recognizing that traditional methods alone may no longer be enough.
But it’s not just the diet industry that’s feeling the impact. The food and beverage industry is also bracing for change. With GLP-1 users consuming fewer calories, companies are rethinking their product lines. Nestlé, for example, launched Vital Pursuit, a line of frozen meals specifically designed for GLP-1 users. Meanwhile, gyms are adapting by offering personalized training programs tailored to the unique needs of people taking these medications.
How GLP-1s Are Shaping Employee Health Insurance
It’s not just industries that are adapting—employee health insurance plans are feeling the pressure too. As GLP-1s become more popular, employers are increasingly covering these medications in their health plans (this is one of the many trends to see evolve). About one-third of employers now offer GLP-1 coverage for both diabetes and weight loss, up from just 26% last year. This trend reflects a growing recognition of the importance of managing obesity as a chronic condition.
But there’s a catch: these drugs come with a hefty price tag, often exceeding $10,000 per patient per year (~$1,000 to $1,500 per month). While the potential long-term savings in healthcare costs (thanks to reduced rates of chronic conditions like diabetes and hypertension) are appealing, the upfront costs are significant. One has to think about the accessibility and affordability inequities that are emerging with GLP-1—will this become a drug JUST for the upper class? To manage these expenses, many health plans are implementing cost-control measures like prior authorization. Not to mention the effect of a potential generic GLP-1 medication that could break down the inequity barriers.
For employers, offering coverage for GLP-1s could be a smart move for attracting and retaining talent in a competitive job market. But it’s also a balancing act—one that requires careful consideration of the potential benefits versus the costs.
A White Space Opportunity for Suzy Trackers
Here’s where Suzy comes in. As the GLP-1 revolution unfolds, it’s more important than ever to track consumer behavior and market trends. But why stop at just understanding what’s happening now? We know GLP-1 medications will be revolutionizing consumer behaviors for decades to come affecting almost all industries. Suzy’s Trackers can help you identify white-space opportunities that others might miss.
The demand for these medications is only going to grow, and the implications are vast. From understanding consumer behavior to predicting market trends, the insights you can gain are endless.
For example, consider this research question: “How are GLP-1 medications influencing consumer preferences for diet and fitness products?” This question isn’t just timely—it’s a goldmine for businesses looking to adapt to the changing landscape. By tracking how GLP-1 users and non-users are altering their eating habits, exercise routines, and product choices, you can gain valuable insights that inform your strategy.
But that’s just the beginning. Suzy’s platform can also help you explore questions like, “What new product categories could emerge as a result of the GLP-1 revolution?” or “How do GLP-1 users perceive traditional weight loss methods?” These insights can drive innovation, helping you stay ahead of the competition and capitalize on emerging trends.
By leveraging Suzy’s platform, you can make data-driven decisions that not only keep you competitive but also position you as a leader in the health and wellness space. So, let’s get started. The future of weight loss is here, and it’s powered by GLP-1s.
The Bottom Line
The GLP-1 revolution is changing the game in weight loss culture, particularly in a post-lockdown world. These medications offer a promising solution to a complex problem, but they also come with challenges—namely, high costs and questions about long-term efficacy. As this landscape continues to evolve, it’s crucial to stay informed and proactive.
Regardless of your industry, understanding the impact of GLP-1s is no longer optional—it’s essential. So, why not start tracking consumer behaviors on Suzy today? After all, in the ever-changing world of weight loss, knowledge isn’t just power—it’s profit.
Want to learn more about tracking? Book a demo with our team today to see how our platform works.
